Enhancing Obesity Treatment Pricing in South Af...

By João L. Carapinha

April 2, 2026

Novo Nordisk has cut the price of Wegovy for the second time in South Africa, making obesity treatment pricing South Africa a key focus for improved patient access. The latest reductions, announced on 25 March 2026, lower the lowest injectable dos...
Real-World Evidence Integration into Cancer HTA: Scotland’s Success Story
Personalised Fertility Endometriosis Care in the UK
EU-India Pharmaceutical Trade: Opportunities and Challenges in Biopharmaceuti...
Nonclinical Safety Testing with Virtual Control Groups
Advancing Health Technology Assessment MENA: Insights and Implications for th...
Advancing Participatory Arts Health in Dutch Care Systems
Tarlatamab for Small Cell Lung Cancer Treatment
FDA Approves Once-Weekly Basal Insulin Awiqli® for Type 2 Diabetes Management
Inflation Reduction Act Impact on Clinical Trial Investment Trends
EU Alzheimer Approval Challenges: Anavex Withdraws Blarcamesine Application A...
South Africa Health Reform: Revitalizing the Crisis-Stricken Sector
NICE Pembrolizumab Recommendation for Locally Advanced Head and Neck Cancer T...